Treatment
-
More Choices to Treat Lung CancerAdvances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.
by Kendall K. Morgan
-
Forward Look
What’s Next? Fall 2020A therapeutic vaccine targeting advanced cervical cancer.
by Anna Azvolinsky
-
Worth the WaitNeoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
-
Facts and Stats
A Brief History of Checkpoint InhibitorsThe advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.
by Bradley Jones
-
Targeted Therapy for Early-Stage Lung Cancer?A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Support Grows for Making Transfusions a Part of HospiceBlood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.
by Jon Kelvey
-
In It for the Long HaulDoctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
-
From the Editor-in-Chief
Measuring a Cancer Drug’s EffectivenessSurrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
by William G. Nelson, MD, PhD
-
Forward Look
Cancer Treatments and Antioxidant Supplements Can Be a Bad MixChristine Ambrosone on what her research shows.
by Sue Rochman
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
